Enzo Biochem (ENZ) News Today $0.35 0.00 (0.00%) Closing price 04/15/2025 03:59 PM EasternExtended Trading$0.34 -0.01 (-2.58%) As of 04/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Top Research Reports for AbbVie, TJX & Charles SchwabApril 15 at 7:15 PM | finance.yahoo.comEnzo Biochem to delist from NYSE, move to OTCQX marketMarch 30, 2025 | investing.comEnzo Biochem to delist stock from NYSEMarch 29, 2025 | markets.businessinsider.comEnzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQXMarch 28, 2025 | globenewswire.comHere’s Why Enzo Biochem (ENZ) Declined in Q4March 24, 2025 | msn.comENZ Stock Down Following Q2 Earnings, Revenues Decline Y/YMarch 21, 2025 | finance.yahoo.comEnzo Biochem, Inc.: Enzo Biochem Reports Second Quarter Fiscal Year 2025 ResultsMarch 18, 2025 | finanznachrichten.deEnzo Biochem reports Q2 revenue $7.3M vs. $6.2M in Q1March 18, 2025 | markets.businessinsider.comEnzo Biochem Reports Second Quarter Fiscal Year 2025 ResultsMarch 17, 2025 | globenewswire.comEnzo Biochem stock hits 52-week low at $0.51 amid challengesFebruary 13, 2025 | msn.comEnzo Biochem stock hits 52-week low at $0.63 amid market challengesJanuary 27, 2025 | msn.comEnzo Biochem settles lawsuit over 2023 ransomware attack for $7.5MJanuary 16, 2025 | msn.comNYSE notifies Enzo Biochem not in compliance with certain requirementsJanuary 16, 2025 | markets.businessinsider.comEnzo Biochem settles class action for $7.5 millionJanuary 16, 2025 | msn.comEnzo Biochem, Inc.: Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing RulesJanuary 15, 2025 | finanznachrichten.deEnzo Biochem Faces NYSE Compliance ChallengesJanuary 14, 2025 | tipranks.comEnzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing RulesJanuary 14, 2025 | globenewswire.comEnzo Biochem, Inc. Reports Fiscal Q1 2024 Financial Results and Declares Special Cash DividendDecember 18, 2024 | nasdaq.comEnzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024)December 18, 2024 | finance.yahoo.comStockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)StockNews.com started coverage on shares of Enzo Biochem in a report on Tuesday. They set a "hold" rating on the stock.December 17, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Announces Quarterly Earnings ResultsEnzo Biochem (NYSE:ENZ - Get Free Report) issued its quarterly earnings data on Monday. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.December 16, 2024 | marketbeat.comEnzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company UpdateDecember 16, 2024 | globenewswire.comStockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)StockNews.com began coverage on shares of Enzo Biochem in a report on Monday. They issued a "hold" rating for the company.December 9, 2024 | marketbeat.comThe Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo BiochemDecember 5, 2024 | uk.finance.yahoo.comTop Stock Reports for Amgen, Eaton & Enzo BiochemDecember 5, 2024 | msn.comEnzo Biochem, Inc. (NYSE:ENZ) Short Interest Down 9.3% in NovemberEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 433,000 shares, a drop of 9.3% from the October 31st total of 477,500 shares. Based on an average daily volume of 86,700 shares, the days-to-cover ratio is currently 5.0 days. Currently, 1.2% of the company's stock are sold short.December 2, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.comStockNews.com began coverage on shares of Enzo Biochem in a research note on Sunday. They set a "hold" rating for the company.December 1, 2024 | marketbeat.comEnzo Biochem Appoints Jon Couchman to BoardNovember 26, 2024 | markets.businessinsider.comEnzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.comStockNews.com began coverage on shares of Enzo Biochem in a research note on Saturday. They issued a "hold" rating on the stock.November 23, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Now Covered by StockNews.comStockNews.com began coverage on Enzo Biochem in a research note on Friday. They set a "hold" rating for the company.November 15, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock, Option ChainNovember 11, 2024 | benzinga.comEnzo Biochem, Inc.: Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendNovember 4, 2024 | finanznachrichten.deEnzo Biochem Reports Revenue Growth Despite LossesOctober 31, 2024 | markets.businessinsider.comEnzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023)October 31, 2024 | finance.yahoo.comWe're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn RateOctober 31, 2024 | finance.yahoo.comEnzo Biochem (NYSE:ENZ) Stock Price Passes Above 200 Day Moving Average - Should You Sell?Enzo Biochem (NYSE:ENZ) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?October 30, 2024 | marketbeat.comEnzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendOctober 29, 2024 | globenewswire.comEnzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.comStockNews.com started coverage on Enzo Biochem in a research report on Tuesday. They issued a "hold" rating on the stock.October 22, 2024 | marketbeat.comEnzo Biochem, Inc. (NYSE:ENZ) Sees Significant Increase in Short InterestEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 518,000 shares, a growth of 8.2% from the September 15th total of 478,700 shares. Approximately 1.4% of the shares of the stock are short sold. Based on an average daily volume of 74,600 shares, the days-to-cover ratio is currently 6.9 days.October 17, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comEnzo Biochem (NYSE:ENZ) Shares Pass Above 200-Day Moving Average of $1.13Enzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.13September 28, 2024 | marketbeat.comRecombinant Proteins Market Size to Reach USD 5.0 Billion by 2032, at a CAGR of 7.6% - SNS InsiderSeptember 25, 2024 | finance.yahoo.comWorried About Financial Fraud After A Healthcare Data Breach? Here's What You Can DoSeptember 25, 2024 | forbes.comConnecticut Attorney General announces $1.7 million false claims settlement with Enzo Clinical LabsSeptember 21, 2024 | msn.comEnzo Biochem Inc (EZB.DU)September 20, 2024 | ca.finance.yahoo.comEnzo Biochem (NYSE:ENZ) Share Price Crosses Above 200-Day Moving Average of $1.14Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above 200-Day Moving Average of $1.14September 20, 2024 | marketbeat.comShort Interest in Enzo Biochem, Inc. (NYSE:ENZ) Declines By 10.0%Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 531,800 shares, a decline of 10.0% from the July 15th total of 591,200 shares. Based on an average trading volume of 119,600 shares, the short-interest ratio is presently 4.4 days. Currently, 1.5% of the shares of the stock are sold short.August 18, 2024 | marketbeat.comUnicoin hints at potential data meddling after G-Suite compromiseAugust 16, 2024 | msn.comBiotech company settles for $4.5M after cybercriminals use decade-old password in massive data breach: NY AGAugust 14, 2024 | msn.comEnzo Biochem to pay $4.5m for leaked healthcare data due to lax securityAugust 14, 2024 | finance.yahoo.com Remove Ads Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address ENZ Media Mentions By Week ENZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENZ News Sentiment▼0.000.78▲Average Medical News Sentiment ENZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENZ Articles This Week▼01▲ENZ Articles Average Week Remove Ads Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OpGen News Today Burning Rock Biotech News Today Concord Medical Services News Today Marpai News Today BioRestorative Therapies News Today Kindly MD News Today Mangoceuticals News Today Ontrak News Today SunLink Health Systems News Today Agape ATP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENZ) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
